Evidence map›Paper›PMID 34196228›Full record

ArticleJournal of diabetes science and technology2021

Diabetes Technology Meeting 2020.

Trisha Shang, Jennifer Y Zhang, B Wayne Bequette, Jennifer K Raymond, Gerard Coté, Jennifer L Sherr, Jessica Castle, John Pickup, Yarmela Pavlovic, Juan Espinoza and 8 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of diabetes science and technology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 12 institutions in 3 countries.

Trisha ShangDiabetes Technology Society, Burlingame, CA, USA.ORCID 0000-0001-9687-9336
Jennifer Y ZhangDiabetes Technology Society, Burlingame, CA, USA.ORCID 0000-0002-3374-9777
B Wayne BequetteRensselaer Polytechnic Institute, Troy, NY, USA.ORCID 0000-0002-6472-1902
Jennifer K RaymondChildren's Hospital Los Angeles, University of Southern California, Los Angeles, CA, USA.ORCID 0000-0003-1866-4932
Gerard CotéTexas A & M University, College Station, Texas, USA.ORCID 0000-0002-3164-9625
Jennifer L SherrYale University, New Haven, CT, USA.ORCID 0000-0001-9301-3043
Jessica CastleOregon Health Sciences University, Portland, OR, USA.ORCID 0000-0003-1179-5374
John PickupKing's College London, London, UK.ORCID 0000-0002-4373-3269
Yarmela PavlovicMannatt, Phelps & Phillips, LLP, San Francisco, CA, USA.
Juan EspinozaChildren's Hospital Los Angeles, University of Southern California, Los Angeles, CA, USA.ORCID 0000-0003-0513-588X
Laurel H MesserBarbara Davis Center for Childhood Diabetes, Aurora, CO, USA.ORCID 0000-0001-7493-0989
Tim HeiseProfil, Neuss, Germany.ORCID 0000-0002-8346-2037
Carlos E MendezMedical College of Wisconsin, Milwaukee, WI, USA.ORCID 0000-0003-1875-6124
Sarah KimUniversity of California San Francisco, San Francisco, CA, USA.
Barry H GinsbergDiabetes Technology Consultants, Arlington, Virginia, USA.
Umesh MasharaniUniversity of California San Francisco, San Francisco, CA, USA.ORCID 0000-0002-3269-804X
Rodolfo J GalindoEmory University School of Medicine, Atlanta, GA, USA.
David C KlonoffMills-Peninsula Medical Center, San Mateo, CA, USA.ORCID 0000-0001-6394-6862
Diabetes Technology Society · USUniversity of California, San Francisco · USUniversity of Southern California · USEmory University · USKing's College London · GBMedical College of Wisconsin · USMills Peninsula Health Services · USOregon Health & Science University · USProfil Institute for Metabolic Research · DERensselaer Polytechnic Institute · USTexas A&M University · USYale University · US

Funding

Yale Clinical and Translational Science AwardUL1TR001863 · YALE UNIVERSITY · 2025 to 2025
$9.9M
Technologies Advancing Translation - Regional CoreP30DK111024 · EMORY UNIVERSITY · 2025 to 2025
$775k
Use of Continuous Glucose Monitoring (CGM) in End-Stage Renal Disease(ESRD) Patients with Type 2 DiabetesK23DK123384 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Rodolfo Galindo · 2022 to 2024
$369k
FDA HHS P50 FD006425NCATS NIH HHS UL1 TR001863NIDDK NIH HHS K23 DK123384NIDDK NIH HHS P30 DK111024
6 · The paper itself

Abstract

Diabetes Technology Society hosted its annual Diabetes Technology Meeting on November 12 to November 14, 2020. This meeting brought together speakers to cover various perspectives about the field of diabetes technology. The meeting topics included artificial intelligence, digital health, telemedicine, glucose monitoring, regulatory trends, metrics for expressing glycemia, pharmaceuticals, automated insulin delivery systems, novel insulins, metrics for diabetes monitoring, and discriminatory aspects of diabetes technology. A live demonstration was presented.

Indexed as

Diabetes MellitusDiabetes Mellitus, Type 1Artificial IntelligenceBlood GlucoseBlood Glucose Self-MonitoringHumansTechnologyBlood Glucosediabetesglucoseinsulinmeetingsoftwaretechnology

Identifiers

PMID34196228
PMCPMC8258529
OpenAlexW3176423617

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.